Skip to main content
. 2015 Feb 18;15:66. doi: 10.1186/s12885-015-1073-8

Figure 1.

Figure 1

Immunoaffinity analysis of human recombinant TK1 and serum TK1. (A) Results from the immunoaffinity/Western blotting analysis of purified recombinant human TK1 and the 26 kDa band relative intensity (arbitrary units, A.U.) used as a standard. (B) Examples of results of the immunoaffinity/Western blotting analysis of sera from blood donors, (C) MDS patients, (D) breast cancer, (E) or prostate cancer patients.